PRKACA and cancer: The diagrams in Figure 5B,C and the data in Table S3 demonstrated that protein kinases (AMPK, PRKACA, MEK5/ERK5, GSK3B, PKC and ILK), protein phosphatases (PP2A, PPP1CB, DUSP6 and PTPN5) and proteases (CTSL, CASP7 and CAPN1) are highly enriched in terms of cancer hallmark and cancer pathways terms.